Ticker LaunchSPAC · Merger completed
Panacea Acquisition Corp
Business combination with Nuvation Bio Inc.
Panacea Acquisition Corp is a blank-check company (SPAC) that raised $125M in its initial public offering on Jul 2, 2020, listing on New York Stock Exchange. It completed its business combination with Nuvation Bio Inc. on Feb 10, 2021; the combined company is Nuvation Bio Inc. (NUVB). Needham led the IPO, with J.P. Morgan and TD Cowen. Skadden, Arps advised the SPAC and Greenberg Traurig advised the underwriters on the IPO.
Nuvation Bio Inc. is a biopharmaceutical company focused on discovering, developing and delivering therapies that address significant unmet needs in oncology. It is the target of a business combination with a special purpose acquisition company.
- Status
- Merger completed
- IPO date
- Jul 2, 2020
- IPO size
- $125M
- IPO exchange
- New York Stock Exchange
- Target
- Nuvation Bio Inc. (Legacy Nuvation Bio)
- Announced
- Oct 21, 2020
- Closed
- Feb 10, 2021
- Combined company
- Nuvation Bio Inc. (NUVB)
- IPO underwriters
- Needham, J.P. Morgan and TD Cowen
- SPAC counsel (IPO)
- Skadden, Arps
- Underwriters' counsel (IPO)
- Greenberg Traurig
More on this SPAC for subscribers
- Trust balance and value per share
- Redemptions at each extension and at the merger vote
- Liquidation deadline and extension history
- PIPE and other committed financing
- Merger proxy, registration statement and investor presentation
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- IPO prospectus (424B4) Jul 2, 2020
- Deal announcement (8-K) Oct 21, 2020
- Press release
- All filings on EDGAR CIK 1811063
Other deSPACs that closed in 2021
- Butterfly Network, Inc.via Longview Acquisition Corp. · closed Feb 12, 2021
- PLBY Group, Inc.via Mountain Crest Acquisition Corp. · closed Feb 10, 2021
- Metromile, Inc.via INSU Acquisition Corp. II · closed Feb 9, 2021
- Gemini Therapeutics, Inc.via FS Development Corp. · closed Feb 5, 2021
- Advent Technologies Holdings, Inc.via AMCI Acquisition Corp. · closed Feb 4, 2021
- E2open Parent Holdings, Inc.via CC Neuberger Principal Holdings I · closed Feb 4, 2021